Skip to content

Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis

Visual Processing Speed and Objective Analysis of Supranuclear Ocular Movements Control in Multiple Sclerosis Patients and Its Relationship With OCT and Reading Difficulties

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05706220
Enrollment
120
Registered
2023-01-31
Start date
2022-06-13
Completion date
2025-12-31
Last updated
2025-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, Clinically Isolated Syndrome, Relapsing Remitting Multiple Sclerosis, Progressive Multiple Sclerosis

Keywords

ocular motility disorders, eye movement, eye tracking, microperimetry, fixational eye movements, visual processing speed, optical coherence tomography

Brief summary

This project aims to analyze ocular motility problems, visual processing speed and microperimetry, and their relationship with consolidated retinal structural biomarkers (optical coherence tomography, OCT) in patients with Multiple Sclerosis w/w reading complaints comparing with healthy subjects.

Detailed description

Anamnesis, ophthalmological medical history including difficulties in reading with appropriate glasses. The following protocol will be applied: * Comprehensive eye examination * Stereopsis * Primary gaze position * Cover test: far and near * Vergence and version eye movements * Presence of nystagmus * Far and near best corrected visual acuity, with updated refraction -.Pupillary light reflex * Biomicroscopy of the anterior pole * Intraocular pressure * Recording of eye movements during two standardized tests: International Reading Speed Texts test (IReST®) and Developmental Eye Movement Test (DEM™) with Tobii™ Pro Nano hardware package eye-tracking system and Tobii™ Pro Lab - full edition software. * Visual processing speed * Microperimetry * Optical coherence tomography * Eye fundus * Patients with a history of clinical optic neuritis will additionally undergo contrast sensitivity tests, the Farnsworth® test (Farnsworth test 28 Hue x 100) and normal monocular perimetry using the standard Swedish Interactive Thresholding Algorithm (SITA-central 24-2) perimeter test. Humphrey® (Humphrey visual field analyser) and other tests at the discretion of the investigator.

Interventions

DIAGNOSTIC_TESTEye tracking

Eye tracker will be used to evaluate eye movements

DIAGNOSTIC_TESTMicroperimetry

Perimetric examination with Expert Exam strategy Microperimetry be used for fixation test

DIAGNOSTIC_TESTOptical coherence tomography (OCT)

Macular Cube 512x128 or 200x200 scan. OCT will be used to analysis of retinal nerve fiber layer, ganglion cell complex and ganglion-cell/inner plexiform layer

DIAGNOSTIC_TESTVisual processing speed test

Visual processing speed test will be used for assessing subject visual stimulus search and reach times. Thirty-two different everyday visual stimuli divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities.

Sponsors

Fundación Eugenio Rodríguez Pascual
CollaboratorUNKNOWN
Hospital del Rio Hortega
CollaboratorOTHER
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of Multiple Sclerosis * Best distant corrected visual acuity equal or greater than 0.7 (decimal scale). Glasses or soft contact lenses users. * Best close corrected visual acuity equal to or greater than 20/30 (Snellen scale).Glasses or soft contact lenses users.

Exclusion criteria

* Patients with a history of acute optic neuritis (ON) and/or who experienced an episode of ON \<6 months prior to the study, to avoid potential interference of papilledema with accurate peripapillary RNFL thickness measurements. * Patients with other retinal and optic nerve diseases, advanced cataracts according to the international Lens Opacities Classification System III (LOCS III) (opacities greater than C2N2) * Patients with other ophthalmological diseases that could affect central visual acuity * Subjects with high refractive error (+ - 6 diopters). * Subjects with other demyelinating disorders (neuromyelitis optica or acute disseminated encephalomyelitis).

Design outcomes

Primary

MeasureTime frameDescription
Eye Tracking Data24 HoursCharacteristics of eye movements recorded with the eye tracker system during reading tests
Values for Visual Processing Speed (VPS)24 HoursVPS will be assessing subject visual stimulus search reaction time (S-RT) and reach reaction time (R-RT), measured in seconds. Thirty-two different everyday visual stimuli were divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities (10º, 20º y 30º)
Retinal sensitivity assessed by microperimetry24 HoursSensitivity and fixation analysis with microperimetry
Values for OCT neuroretinal and peripapillary parameters24 HoursOCT assessment will be by spectral domain-optical coherence tomography to assess the retinal nerve fiber layer thickness and macular volume in humans

Secondary

MeasureTime frameDescription
Preferred Retinal Locus (PRL) analysis with microperimetry24 HoursPRL assessment: Low-PRL, PRL High
Analysis of the macular integrity (MI) with microperimetry24 HoursMI assessment: macular integrity index
Fixations recorded with the eye tracker system24 Hoursnumber of fixations, duration in milliseconds
Retinal Nerve Fiber Layer measurement (RNFL: peri-papillary OCT)24 HoursOptical Coherence Tomography (OCT) will be used to assess the RNFL of patients with multiple sclerosis
Macular ganglion cell-inner plexiform layer thickness measurement (GCIPL)24 HoursOptical Coherence Tomography (OCT) will be used to assess the GCIPL of patients with multiple sclerosis
Ganglion Cell Layer measurement (GCL: Macular OCT)24 HoursOptical Coherence Tomography (OCT) will be used to assess the GCL of patients with multiple sclerosis
Saccades recorded with the eye tracker system24 Hoursnumber of saccades, duration in milliseconds
Fixation assessment with microperimetry24 HoursFixation assessment: P1, P2 fixation points (indexes P1 and P2)
Bivariate Contour Ellipse Area (BCEA) analysis with microperimetry24 HoursBCEA assessment: areas BCEA 63, BCEA 95

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026